top of page


News & Updates
Follows our journey in developing the best therapeutics for patients with EBV-associated malignancies


mRNA Therapy for Nasopharyngeal Cancer Selected as One of Hong Kong's Top 10 Innovative Science News in 2024
ACE NanoMed is proud to announce that the groundbreaking research on the mRNA drug for treating nasopharyngeal cancer, titled " New mRNA...
Feb 5


ACE NanoMed Selected for Prestigious Incu-Bio Program at HKSTP
ACE NanoMed is excited to announce its selection to participate in the renowned Incu-Bio program at the Hong Kong Science and Technology...
Sep 2, 2024


Groundbreaking Development: Innovative mRNA Drug for Nasopharyngeal Cancer
Professor K.W. Lo and Professor Anna Tsang, together with some industry experts and collaborators, hosted a press conference organized by...
Jun 27, 2024


Professor K.W. Lo and Professor Anna Tsang of ACE NanoMed win Silver Medals at the 49th International Exhibition of Inventions Geneva 2024
ACE NanoMed, a leading drug research and development company, is proud to announce that Professor K.W. Lo and Professor Anna Tsang,...
Apr 20, 2024


ACE NanoMed Limited: Revolutionizing Cancer Treatment With Innovative Drug Solutions
ACE NanoMed, A Biomedical Company Specializing In The Development Of Advanced Therapies For Cancers Associated With The Epstein-Barr...
Dec 1, 2023


ACE NanoMed Limited Emerges As Champion In CUHK Innovation Day 2023'S Elevator Pitch Competition
ACE NanoMed Limited, A Leading Innovator In The Field Of Nanomedicine, Emerged As The Champion Of The CUHK Innovation Day 2023'S Elevator...
Dec 1, 2023
bottom of page